Cargando…

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota

Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Suriano, Francesco, Manca, Claudia, Flamand, Nicolas, Van Hul, Matthias, Delzenne, Nathalie M., Silvestri, Cristoforo, Cani, Patrice D., Di Marzo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913869/
https://www.ncbi.nlm.nih.gov/pubmed/36766753
http://dx.doi.org/10.3390/cells12030411
_version_ 1784885532547874816
author Suriano, Francesco
Manca, Claudia
Flamand, Nicolas
Van Hul, Matthias
Delzenne, Nathalie M.
Silvestri, Cristoforo
Cani, Patrice D.
Di Marzo, Vincenzo
author_facet Suriano, Francesco
Manca, Claudia
Flamand, Nicolas
Van Hul, Matthias
Delzenne, Nathalie M.
Silvestri, Cristoforo
Cani, Patrice D.
Di Marzo, Vincenzo
author_sort Suriano, Francesco
collection PubMed
description Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (ob/ob) and diabetic (db/db) mice to decipher possible correlations between these mediators and intestinal inflammation and gut microbiota composition. Basal lipid and gene expression profiles, measured by LC/MS-MS-based targeted lipidomics and qPCR transcriptomics, respectively, highlighted a differentially altered intestinal eCBome and oxylipin tone, possibly linked to increased mRNA levels of inflammatory markers in db/db mice. In particular, the duodenal levels of several 2-monoacylglycerols and N-acylethanolamines were increased and decreased, respectively, in db/db mice, which displayed more pronounced intestinal inflammation. To a little extent, these differences were explained by changes in the expression of the corresponding metabolic enzymes. Correlation analyses suggested possible interactions between eCBome/oxylipin mediators, cytokines, and bacterial components and bacterial taxa closely related to intestinal inflammation. Collectively, this study reveals that db/db mice present a higher inflammatory state in the intestine as compared to ob/ob mice, and that this difference is associated with profound and potentially adaptive or maladaptive, and partly intestinal segment-specific alterations in eCBome and oxylipin signaling. This study opens the way to future investigations on the biological role of several poorly investigated eCBome mediators and oxylipins in the context of obesity and diabetes-induced gut dysbiosis and inflammation.
format Online
Article
Text
id pubmed-9913869
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99138692023-02-11 A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota Suriano, Francesco Manca, Claudia Flamand, Nicolas Van Hul, Matthias Delzenne, Nathalie M. Silvestri, Cristoforo Cani, Patrice D. Di Marzo, Vincenzo Cells Article Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (ob/ob) and diabetic (db/db) mice to decipher possible correlations between these mediators and intestinal inflammation and gut microbiota composition. Basal lipid and gene expression profiles, measured by LC/MS-MS-based targeted lipidomics and qPCR transcriptomics, respectively, highlighted a differentially altered intestinal eCBome and oxylipin tone, possibly linked to increased mRNA levels of inflammatory markers in db/db mice. In particular, the duodenal levels of several 2-monoacylglycerols and N-acylethanolamines were increased and decreased, respectively, in db/db mice, which displayed more pronounced intestinal inflammation. To a little extent, these differences were explained by changes in the expression of the corresponding metabolic enzymes. Correlation analyses suggested possible interactions between eCBome/oxylipin mediators, cytokines, and bacterial components and bacterial taxa closely related to intestinal inflammation. Collectively, this study reveals that db/db mice present a higher inflammatory state in the intestine as compared to ob/ob mice, and that this difference is associated with profound and potentially adaptive or maladaptive, and partly intestinal segment-specific alterations in eCBome and oxylipin signaling. This study opens the way to future investigations on the biological role of several poorly investigated eCBome mediators and oxylipins in the context of obesity and diabetes-induced gut dysbiosis and inflammation. MDPI 2023-01-25 /pmc/articles/PMC9913869/ /pubmed/36766753 http://dx.doi.org/10.3390/cells12030411 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Suriano, Francesco
Manca, Claudia
Flamand, Nicolas
Van Hul, Matthias
Delzenne, Nathalie M.
Silvestri, Cristoforo
Cani, Patrice D.
Di Marzo, Vincenzo
A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title_full A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title_fullStr A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title_full_unstemmed A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title_short A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
title_sort lipidomics- and transcriptomics-based analysis of the intestine of genetically obese (ob/ob) and diabetic (db/db) mice: links with inflammation and gut microbiota
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913869/
https://www.ncbi.nlm.nih.gov/pubmed/36766753
http://dx.doi.org/10.3390/cells12030411
work_keys_str_mv AT surianofrancesco alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT mancaclaudia alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT flamandnicolas alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT vanhulmatthias alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT delzennenathaliem alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT silvestricristoforo alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT canipatriced alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT dimarzovincenzo alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT surianofrancesco lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT mancaclaudia lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT flamandnicolas lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT vanhulmatthias lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT delzennenathaliem lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT silvestricristoforo lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT canipatriced lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota
AT dimarzovincenzo lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota